Gastrointestinal symptoms dominate
For those already managing diabetes or for individuals considering these drugs solely for weight management, the stakes may be high because eye-related changes can be lasting
27,3537 Moreover, despite the efficacy of potent caspase inhibitors, they failed to prevent APAP-induced cell death
What to Expect During the Process While GLP-1 treatments can lead to significant weight loss, its important to approach this journey with realistic expectations and proper guidance
The logic is that bupropion + naltrexone (Contrave) addresses reward-driven eating and appetite, while topiramate independently suppresses cravings through a different brain mechanism
Side Effects and Safety Considerations The most common side effects across GLP1/GIP/glucagon agonists include: Nausea, vomiting, or reduced appetite that feels too strong. Diarrhea or constipation